Immune-mediated inflammatory disease (IMID) is a group of unrelated conditions that lack a definitive etiology, but share a common inflammatory pathway leading to inflammation.
Immune-mediated Inflammatory Diseases: Introduction
- Immune-mediated inflammatory disease (IMID) is a group of unrelated conditions that lack a definitive etiology, but share a common inflammatory pathway leading to inflammation. Immune-mediated diseases are conditions triggered by over activity or abnormal activity of the body’s immune system. All immune-mediated inflammatory diseases (IMID) can cause organ damage, and are associated with increased morbidity and/or mortality.
- The normal immune system is a complex system that protects our bodies from infections. The white blood cells or lymphocytes help us fight the infection when our body becomes infected with a bacteria, virus, or parasite.
- Some of the well-known immune-mediated inflammatory or autoimmune diseases include ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's disease, Behcet's disease, arthritis, inflammatory bowel disease (IBD), systemic lupus erythematosus, insulin-dependent (type 1) diabetes mellitus, and various allergies (eczema, hives, hay fever, asthma attacks, food allergies, etc.), as well as many cardiovascular, neuromuscular, and infectious diseases
Read Report Overview - https://www.transparencymarketresearch.com/immune-mediated-inflammatory-disease-treatment-market.html
Key Drivers and Restraints of Global Immune-mediated Inflammatory Disease Treatment Market
- The number of people affected with autoimmune diseases is rising consistently across the world. The root cause of a number of these diseases can be traced to a lack of healthy lifestyle and dietary habits and genetics that can trigger these diseases. Rise in the number of these diseases propels the global immune-mediated inflammatory disease treatment market.
- Cardiovascular and respiratory diseases have affected a large number of individuals globally, and are the leading cause of death among the global population
- Increase in incidence of chronic diseases of the liver, heart, kidneys, pancreas, and blood disorders have augmented the demand for immune-mediated inflammatory disease treatment. Therefore, a rise in the incidence of autoimmune diseases across the globe fuels the global immune-mediated inflammatory disease treatment market.
- However, lack of patient awareness, side effects associated with drugs, and poor reimbursement is anticipated to hamper market growth during the forecast period
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77629
Asthma and COPD to Lead Global Market
- The global immune-mediated inflammatory disease treatment market can be segmented based on treatment type, indication, distribution channel, and region
- In terms of treatment type, the global immune-mediated inflammatory disease treatment market can be classified into traditional drugs (corticosteroids, non-steroidal anti-inflammatory drugs, anti-TNF agents, etc.), targeted biologic therapies, and novel therapies. Based on indication, the global market can be categorized into asthma, chronic obstructive pulmonary diseases (COPD), inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), psoriasis, and others. In terms of distribution channel, the global immune-mediated inflammatory disease market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=77629
Asia Pacific to be Lucrative Market for Immune-mediated Inflammatory Disease Treatments
- The global immune-mediated inflammatory disease treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- Adoption of advanced treatment options is increasing in developing countries, thereby providing opportunities in the global immune-mediated inflammatory disease treatment market
- Availability of superior treatment facilities at quite low prices in developing countries, such as India and China, compared to that in the West is a major factor boosting the immune-mediated inflammatory disease treatment market in Asia Pacific. Growing medical tourism industry in developing countries is anticipated to offer significant opportunities in the immune-mediated inflammatory disease treatment market in the region.
Pre Book Immune-mediated Inflammatory Disease (IMID) Treatment Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=77629<ype=S
Key Players Operating in Global Immune-mediated Inflammatory Disease Treatment Market
Leading players in the global immune-mediated inflammatory disease treatment market include:
- GlaxoSmithKline
- Eli Lilly and Company
- AstraZeneca
- Bristol-Myers
- Sanofi SA
- Roche
More Trending Reports by Transparency Market Research:
Healthcare Informatics Market: Biomedical and health informatics are playing a critical role in the system response to the COVID-19 pandemic. Companies in the healthcare informatics market are capitalizing on this opportunity to help healthcare stakeholders build foundational knowledge, enhance health decision making, and support in data governance. The rapid implementation of technological support for optimizing clinical management of the coronavirus pandemic has become the need of the hour and be prepared for similar future events.
Soft Tissue Market: The logistical considerations surrounding COVID-19 testing has become a part of the weekly routine for orthopedic surgeons. Although it is rare for patients to become COVID-19 positive, owing to scheduled osteochondral allograft (OCA) or the second stage of autologous chondrocyte implantation (ACI), it poses a problem when considering delivery of the expensive tissues. Mass vaccination drives are anticipated to reduce the burden of logistical and other regulatory restrictions.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/